Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 701-394-3 | CAS number: 1782069-81-1
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Endpoint summary
Administrative data
Key value for chemical safety assessment
Genetic toxicity in vitro
Description of key information
The test item did not induce gene mutations or chromosomal aberrations in the V79 Chinese hamster cell line nor gene mutations in S. typhimurium bacterial cells in the presence and absence of metabolic activation.
Link to relevant study records
- Endpoint:
- in vitro cytogenicity / chromosome aberration study in mammalian cells
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 3 March 1986 to 25 April 1986
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 473 (In Vitro Mammalian Chromosome Aberration Test)
- Version / remarks:
- 1983
- Deviations:
- not specified
- Qualifier:
- according to guideline
- Guideline:
- EPA OPPTS 870.5375 - In vitro Mammalian Chromosome Aberration Test
- Version / remarks:
- 1982
- Deviations:
- not specified
- GLP compliance:
- yes
- Type of assay:
- in vitro mammalian cell transformation assay
- Target gene:
- Chinese hamster cell line V79
- Species / strain / cell type:
- Chinese hamster lung fibroblasts (V79)
- Details on mammalian cell type (if applicable):
- CELLS USED
- Source of cells: Laboratory stock
- Suitability of cells: The V79 cell line has been used for many years in in vitro experiments with success. The high proliferation rate and plating efficiency of untreated cells are necessary for the appropriate performance of the study.
- Cell cycle length, doubling time or proliferation index: Doubling time 12 to 16 hours in stock cultures.
- Methods for maintenance in cell culture: Thawed stock cultures were propagated at 37°C in plastic flasks. Seeding was done with 100000 to 300000 cells per flask in 5 mL of MEM-medium supplemented with 10% fetal calf serum. Cells were subcultured twice a week.
- Modal number of chromosomes: 22 - Metabolic activation:
- with and without
- Metabolic activation system:
- rat liver S9
- Test concentrations with justification for top dose:
- The highest concentration should reduce the mitotic index to about 50 % as compared to the solvent control.
7 hour preparation time: 10 μg/mL (without S9) and 36 μg/mL (with S9)
18 hour preparation time: 1, 5 and 11 μg/mL (without S9) and 3, 15 and 36 μg/mL (with S9)
28 hour preparation time: 11 μg/mL (without S9) and 36 μg/mL (with S9) - Vehicle / solvent:
- - Vehicle(s)/solvent(s) used: ethanol (1%)
- Justification for choice of solvent/vehicle: Ethanol is relatively non-toxic in the concentrations applied. - Untreated negative controls:
- yes
- Remarks:
- untreated cultures
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- other: ethyl methanesulfonate (without metabolic activation), cyclophosphamide (with metabolic activation)
- Details on test system and experimental conditions:
- METHOD OF APPLICATION: in suspension
- Cell density at seeding: Two days old logarithmically growing stock cultures more than 50% confluent were trypsinised and a single cell suspension was prepared. The cells were seeded into four parallel plastic tissue culture flasks at a concentration of 300000 cells per flask (7 hour interval) and 150000 cells per flask (18 and 28 hour intervals).
DURATION
- Preincubation period: 48 hours
- Exposure duration: 4 hours
- Expression time (cells in growth medium): 5, 15.5 and 25.5 hours after the start of treatment
- Fixation time: 2.0 (7 hour interval) or 2.5 (18 and 28 hour intervals) hours from addition of colcemid
STAIN: Aceto-orcein
NUMBER OF REPLICATIONS: 4
METHODS OF SLIDE PREPARATION AND STAINING TECHNIQUE USED: Cells were trypsinised and suspended in a hypotonic solution (37.5 mM KCl) for 10 minutes at 37°C. After centrifugation (800 to 1000 rpm) the cell pellets were fixed in three steps with glacial acetic acid/ methanol 1 + 3 and stored overnight at 4°C. The next day the cells were spread on wet and ice cold slides and stained.
NUMBER OF METAPHASE SPREADS ANALYSED PER DOSE: 100 metaphases/flask were scored per test concentration.
DETERMINATION OF CYTOTOXICITY
- Method: Mitotic index
- Any supplementary information relevant to cytotoxicity: Mitotic index was determined in 1000 cells in each replicate. - Rationale for test conditions:
- The test item concentrations were determined in a preliminary experiment using the mitotic index and plating efficiencies as an indicator for toxicity response.
- Evaluation criteria:
- Gaps, breaks, fragments, deletions, exchanges and chromosomal disintegrations were recorded as structural aberrations.
1. The test substance is classified as mutagenic if it induces with one of the concentrations tested a significantly increased aberration rate as compared with the negative control. The significance is obvious either by an enhancement of the rate clearly over the control range or it is proven by adequate biometry.
2. The test substance is classified as mutagenic if there is a concentration related increase in the aberration rates as compared with the solvent controls.
3. The test substance is considered negative when 1 and 2 do not apply. - Statistics:
- No statistical analysis performed as there is no indication of a dose-response relationship.
- Key result
- Species / strain:
- Chinese hamster lung fibroblasts (V79)
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Additional information on results:
- RANGE-FINDING/SCREENING STUDIES: See Table 2.
The sensitivity of the test system was demonstrated by the clearly enhanced structural aberration rates found in the groups treated with the positive control substances.
In only one group of cells treated with the lowest concentration of the test item, a higher number of cells with structural chromosome aberrations as compared to the range of the negative controls was found in the presence of S9 mix at preparation interval 18 h. In all other groups treated with the test item, aberration rates within or near the control range were found. This single higher value alone is not regarded as being sufficient to prove mutagenicity. - Conclusions:
- The test item was not mutagenic to V79 Chinese hamster cell line in vitro in the presence and absence of metabolic activation.
- Executive summary:
The potential of the test item to induce chromosomal aberrations was determined in vitro with cells of the V79 Chinese hamster cell line according to OECD Guideline 473. Chinese hamster lung fibroblasts V79 were treated with the test item at concentrations of 1, 5, 10 and 11 µg/mL without S9-activation and 3, 15 and 36 µg/mL with S9-activation. Cells were incubated with the test item for 4 hours, followed by a 5, 15.5 or 25.5 -hour incubation period in growth medium. Colcemid was added as a fixing agent and the cells were incubated for a further 2.0 or 2.5 hours. The study included negative, solvent and positive (ethyl methanesulfonate and cyclophosphamide) controls . Mutagenicity was evaluated by determining the number of gaps, breaks, fragments, deletions, exchanges and chromosomal disintegrations in 400 metaphases per test concentration. Cytotoxicity was evaluated by determination of mitotic index in 1000 cells in each replicate. The test item was not mutagenic to V79 Chinese hamster cell line in the presence and absence of metabolic activation. This study is considered reliable without restriction (Klimisch 1).
- Endpoint:
- in vitro gene mutation study in bacteria
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- comparable to guideline study
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 471 (Bacterial Reverse Mutation Assay)
- Deviations:
- not applicable
- GLP compliance:
- no
- Type of assay:
- bacterial reverse mutation assay
- Species / strain / cell type:
- S. typhimurium TA 1535, TA 1537, TA 98 and TA 100
- Remarks:
- and TA 1538
- Additional strain / cell type characteristics:
- other: histidine mutation, uvrB deletion, rfa deletion, R-factor presence
- Metabolic activation:
- with and without
- Metabolic activation system:
- Liver postmitochondrial fraction (S-9 from male rats induced with Aroclor 1254)
- Test concentrations with justification for top dose:
- 100, 500, 1000, 5000, 10000 and 15000 μg/plate
Toxic effect sought in the highest concentration. - Vehicle / solvent:
- - Vehicle(s)/solvent(s) used: ethanol
- Untreated negative controls:
- no
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- 9-aminoacridine
- 2-nitrofluorene
- methylmethanesulfonate
- other: 2-aminoanthracene, daunomycin, 1-ethyl-2-nitro-3-nitrosoguanidine, N-methyl-N-nitro-N-nitrosoguanidine; 4-nitro-o-phenylene diamine
- Details on test system and experimental conditions:
- METHOD OF APPLICATION: in agar (plate incorporation)
DURATION
- Exposure duration: 48 hours
NUMBER OF REPLICATIONS: 8 for the solvent control, 4 for the test item
METHODS OF SLIDE PREPARATION AND STAINING TECHNIQUE USED: Colonies were stained with triphenyltetrazolium if counting of bacteria colonies is affected by precipitation.
OTHER:
- Plate composition: 0.1 mL bacteria suspension, 0.1 mL test solution, 0.5 mL Na-phosphate buffer (in trials without metabolic activation), 0.5 mL S-9 mix (in trials with metabolic activation), 2.0 mL soft agar solution - Statistics:
- Standard deviations were calculated.
- Key result
- Species / strain:
- S. typhimurium TA 1535
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not examined
- Positive controls validity:
- valid
- Key result
- Species / strain:
- S. typhimurium TA 1537
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not examined
- Positive controls validity:
- valid
- Key result
- Species / strain:
- S. typhimurium TA 1538
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not examined
- Positive controls validity:
- valid
- Key result
- Species / strain:
- S. typhimurium TA 98
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not examined
- Positive controls validity:
- valid
- Key result
- Species / strain:
- S. typhimurium TA 100
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not examined
- Positive controls validity:
- valid
- Additional information on results:
- TEST-SPECIFIC CONFOUNDING FACTORS
- Solubility: Toxic effect was not achieved at the highest dose due to low solubility of the test substance in the test medium.
- Precipitation: The compound precipitated from the test medium at the dose levels of 5000, 10000 and 15000 μg/plate.
- Definition of acceptable cells for analysis: Where counting of bacterial colonies was not possible because of precipitation of the test substance, the colonies were stained with triphenyltetrazolim chloride before evaluation of the plates. This staining enables the colonies to be distinguished from the precipitate and can then be counted as usual.
HISTORICAL CONTROL DATA
- Positive historical control data: Results were acceptable and within the normal range
- Negative (solvent/vehicle) historical control data: Results were acceptable and within the normal range. - Conclusions:
- The test substance did not show mutagenic activity in S. typhimurium strains TA 98, TA 100, TA 1535, TA 1537 and TA 1538 up to 15000 μg/plate, with and without metabolic activation.
- Executive summary:
The mutagenic potential of the test item was determined in Salmonella typhimurium strains TA 98, TA 100, TA 1535, TA 1537 and TA 1538 using a plate incorporation method similar to OECD Guideline 471. The test substance was incubated with and without metabolic activation (rat liver S-9 mix) at nominal concentrations of 100, 500, 1000, 5000, 10000 and 15000 μg/plate. Two experiments were performed, each consisting of 4 test item replicates and 8 solvent control (ethanol) replicates. 2 -aminoanthracene, 9 -aminoacridine, daunomycin, 1 -ethyl-2 -nitro-3 -nitrosoguanidine, methyl methanesulfonate, N-methyl-N-nitro-N-nitrosoguanidine, 2 -nitrofluorene and 4 -nitro-1,2 -phenylenediamine were tested as the positive controls. The test substance did not show mutagenic activity in any S. typhimurium strain up to 15000 μg/plate, with and without metabolic activation. This study is reliable without restrictions (Klimisch 1).
- Endpoint:
- in vitro gene mutation study in mammalian cells
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 13 July 2017 to 24 August 2017
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 476 (In Vitro Mammalian Cell Gene Mutation Test)
- Version / remarks:
- 2016
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.17 (Mutagenicity - In Vitro Mammalian Cell Gene Mutation Test)
- Version / remarks:
- 2008
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EPA OPPTS 870.5300 - In vitro Mammalian Cell Gene Mutation Test
- Version / remarks:
- 1998
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- JAPAN: Guidelines for Screening Mutagenicity Testing Of Chemicals
- Version / remarks:
- Kanpoan No. 287 (Environmental Protection Agency), Eisei No. 127 (Ministry of Health & Welfare), Heisei 09/10/31 Kikyoku No. 2 (Ministry of International Trade & Industry)
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Type of assay:
- other: in vitro mammalian cell gene mutation test using the Hprt and xprt genes (migrated information)
- Target gene:
- Hprt and xprt
- Species / strain / cell type:
- Chinese hamster lung fibroblasts (V79)
- Details on mammalian cell type (if applicable):
- CELLS USED
- Source of cells: Laboratory cell bank.
- Suitability of cells: The V79 cell line has been used successfully in in vitro experiments for many years, particularly due to the doubling time and cloning efficiency.
- Cell cycle length, doubling time or proliferation index: 12-16 h doubling time in stock cultures and more than 50% cloning efficiency of untreated cells.
- Methods for maintenance in cell culture if applicable: Storage in liquid nitrogen.
- Modal number of chromosomes: 22
MEDIA USED
- Type and identity of media including CO2 concentration if applicable: Cells were cultured in MEM (minimal essential medium) containing Hank’s salts supplemented with 10% foetal bovine serum (FBS), neomycin (5 μg/mL) and amphotericin B (1%). During treatment no FBS was added to the medium. All incubations were done at 37°C with 1.5% carbon dioxide (CO2) in humidified air.
- Properly maintained: yes
- Periodically checked for Mycoplasma contamination: yes
- Periodically checked for karyotype stability: yes
- Periodically 'cleansed' against high spontaneous background: yes - Additional strain / cell type characteristics:
- not applicable
- Metabolic activation:
- with and without
- Metabolic activation system:
- Phenobarbital/β-naphthoflavone induced rat liver S9
- Test concentrations with justification for top dose:
- With metabolic activation: 0.75, 1.5, 3, 6, 8, 10, 12, 16 and 20 μg/mL
Without metabolic activation: 0.78, 1.6, 3.1, 6.25, 12.5, 25, 50 and 100 μg/mL
The top dose was chosen to have a relevant cytotoxic effect, indicated by a relative cloning efficiency of 50% or below. - Vehicle / solvent:
- - Vehicle(s)/solvent(s) used: DMSO (1.0% v/v)
- Justification for choice of solvent/vehicle: The solvent was chosen for its solubility properties and its relative non-toxicity to the cell cultures. - Untreated negative controls:
- no
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- 7,12-dimethylbenzanthracene
- ethylmethanesulphonate
- Details on test system and experimental conditions:
- METHOD OF APPLICATION: in medium
- Cell density at seeding: 2.0×10^6 cells per test vessel
DURATION
- Preincubation period: 24 hours
- Exposure duration: 4 hours
- Expression time (cells in growth medium): 7 days
- Fixation time (start of exposure up to fixation or harvest of cells): 8 days
STAIN (for cytogenetic assays): 10% methylene blue in 0.01% KOH solution
NUMBER OF REPLICATIONS: 5 (+ 2 for determination of cytotoxicity)
NUMBER OF CELLS EVALUATED: Stained colonies with more than 50 cells were counted.
DETERMINATION OF CYTOTOXICITY
- Method: cloning efficiency
- Any supplementary information relevant to cytotoxicity: Cloning efficiency was determined after exposure to the test item (survival) and after the expression time (viability). - Rationale for test conditions:
- Two parallel cultures were used throughout the assay. In order to establish a concentration response effect of the test item at least four concentration levels are tested. To overcome problems with possible deviations in toxicity the main experiment was started with more than four concentrations.
- Evaluation criteria:
- A test item is classified as clearly mutagenic if, in any of the experimental conditions examined, all of the following criteria are met:
a) at least one of the test concentrations exhibits a statistically significant increase compared with the concurrent negative control,
b) the increase is dose-related when evaluated with an appropriate trend test,
c) any of the results are outside the distribution of the historical negative control data (e.g. Poisson-based 95% control limits).
A test item is classified as clearly non-mutagenic if, in all experimental conditions examined, all of the following criteria are met:
a) none of the test concentrations exhibits a statistically significant increase compared with the concurrent negative control,
b) there is no concentration-related increase when evaluated with an appropriate trend test,
c) all results are inside the distribution of the historical negative control data (based 95% control limits).
In cases when the response is neither clearly negative nor clearly positive as described above, or in order to judge the biological relevance of a result, the data was evaluated by expert judgement or further investigations. - Statistics:
- A linear regression (least squares) was performed to assess a possible dose dependent increase of mutant frequencies. A trend is judged as significant whenever the p-value (probability value) is below 0.05 when compared to the solvent control groups. A t-Test was performed to evaluate an isolated increase of the mutation frequency at a test point exceeding the 95% confidence interval. Again a t-test is judged as significant if the p-value (probability value) is below 0.05. Both biological and statistical significance were considered together.
- Key result
- Species / strain:
- Chinese hamster lung fibroblasts (V79)
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not examined
- Positive controls validity:
- valid
- Additional information on results:
- TEST-SPECIFIC CONFOUNDING FACTORS
- Effects of pH: No relevant shift of pH of the medium even at the maximum concentration of the test item.
- Effects of osmolality: No relevant shift of osmolarity of the medium even at the maximum concentration of the test item.
- Precipitation: Precipitation was observed at the end of the treatment in the three highest test concentation without metabolic activation (12, 16 and 20 μg/mL) and the two highest test concentration with metabolic activation (50 and 100 μg/mL). Mutation rate was not assessed for these precipitating test concentrations (except at 50 μg/mL, mutation rate was assessed).
- Other confounding effects: Severe cytotoxicity was observed in the four highest test concentation without metabolic activation (10, 12, 16 and 20 μg/mL), therefore mutation rate was not assessed for these cytotoxic test concentrations. The data at 8.0 μg/mL without metabolic activation were rejected as severe cytotoxicity was observed, therefore the mutant frequency was not taken into the consideration of the evaluation of this assay.
RANGE-FINDING/SCREENING STUDIES: The first pre-experiment was performed in the presence and absence of metabolic activation for test item concentrations between 15.6 and 2000 μg/mL. A relevant cytotoxic effect (indicated by a relative cloning efficiency of 50% or below) was observed at 15.6 μg/mL and above without metabolic activation and at 125.0 μg/mL and above with metabolic activation. Due to strong toxic effects in the absence of S9 mix, this part of the pre-experiment was repeated with lower concentrations (0.78 μg/mL to 50 μg/mL). In the second pre-experiment, relevant cytotoxic effect was observed at 12.5 μg/mL and above without metabolic activation.
HISTORICAL CONTROL DATA (with ranges, means and standard deviation and confidence interval (e.g. 95%)
- Positive historical control data: Number of mutant colonies per 10^6 cells, without metabolic activation: mean 190.3, range 53.9 to 872.3, standard deviation 88.4, 95% confidence limit not reported. Number of mutant colonies per 10^6 cells, with metabolic activation: mean 215.8, range 56.7 to 739.9, standard deviation 110.9, 95% confidence limit not reported.
- Negative (solvent) historical control data: Number of mutant colonies per 10^6 cells, without metabolic activation: mean 15.9, range 3.4 to 41.0, standard deviation 7.1, 95% confidence limit 1.7 to 30.2. Number of mutant colonies per 10^6 cells, with metabolic activation: mean 15.7, range 2.4 to 39.2, standard deviation 6.8, 95% confidence limit 2.0 to 29.4. - Conclusions:
- The test item did not induce gene mutations at the HPRT locus in V79 cells. Therefore, the test item is considered to be non-mutagenic in the HPRT assay.
- Executive summary:
The potential of the test item to induce gene mutations at the HPRT locus in V79 cells of the Chinese hamster was determined according to OECD Guideline 476, EU Method B.17, EPA OPPTS 870.5300 and Japanese guidelines. The study was conducted in medium at test item concentrations of 0.75, 1.5, 3, 6, 8, 10, 12, 16 and 20 μg/mL in the absence metabolic activation and 0.78, 1.6, 3.1, 6.25, 12.5, 25, 50 and 100 μg/mL in the presence of metabolic activation. A solvent control and positive controls were tested concurrently. Five replicates were assessed per test item treatment and control, and two parallel cultures were used throughout the assay. The treatment period was 4 hours with and without metabolic activation, with a 24 hour pre-exposure period and 7 day expression (post-exposure) period in medium. Cells were fixed and stained with 10% methylene blue in 0.01% KOH solution 8 days after treatment. Precipitation and / or severe cytotoxicity were observed in the four highest test concentation without metabolic activation (10, 12, 16 and 20 μg/mL) and at the highest test concentration with metabolic activation (100 μg/mL), therefore mutation frequency was not assessed for these concentrations. Severe cytotoxicity also occurred in the 8 μg/mL treatment level without metabolic activation, and this data was not taken into the consideration of the evaluation of this assay. No relevant and reproducible increase in mutant colony numbers per 10^6 cells was observed with and without metabolic activation. Therefore, the test item is considered to be non-mutagenic in the HPRT assay. This study is considered to be reliable without restrictions (Klimisch 1).
Referenceopen allclose all
Table 1. Mutagenicity data and mitotic index
Preparation time | Treatment group | Total cells analysed | Number of aberrant cells including gaps | % of aberrant cells including gaps | Number of aberrant cells excluding gaps | % of aberrant cells excluding gaps | % of aberrant cell exchanges | % mitotic index (absolute) | % mitotic index (relative) |
18 hours | Untreated control -S9 | 400 | 9 | 2.25 | 5 | 1.25 | 0.25 | 6.8 | 100.0 |
18 hours | Untreated control +S9 | 400 | 24 | 6.00 | 7 | 1.75 | 0.00 | 6.0 | 100.0 |
18 hours | Solvent control -S9 | 400 | 17 | 4.25 | 4 | 1.00 | 0.00 | 4.8 | 100.0 |
18 hours | Solvent control +S9 | 400 | 14 | 3.50 | 9 | 2.25 | 0.25 | 5.4 | 100.0 |
18 hours | Positive control -S9 | 200 | 60 | 60.00 | 52 | 52.00 | 45.00 | 7.7 | 113.2 |
18 hours | Positive control +S9 | 200 | 69 | 69.00 | 65 | 65.00 | 39.00 | 4.3 | 71.6 |
18 hours | 1 μg/mL test item -S9 | 400 | 23 | 5.75 | 10 | 2.50 | 0.00 | 4.6 | 95.6 |
18 hours | 3 μg/mL test item +S9 | 400 | 37 | 9.25 | 19 | 4.75 | 0.00 | 4.5 | 83.6 |
18 hours | 5 μg/mL test item -S9 | 400 | 19 | 4.75 | 5 | 1.25 | 0.25 | 5.6 | 115.6 |
18 hours | 15 μg/mL test item +S9 | 400 | 13 | 3.25 | 4 | 1.00 | 0.50 | 2.9 | 54.2 |
18 hours | 11 μg/mL test item -S9 | 400 | 17 | 4.25 | 11 | 2.75 | 0.50 | 3.2 | 65.8 |
18 hours | 36 μg/mL test item +S9 | 400 | 21 | 5.25 | 5 | 1.25 | 0.00 | 7.5 | 139.8 |
7 hours | Solvent control -S9 | 400 | 16 | 4.00 | 4 | 1.00 | 0.00 | 5.9 | 100.0 |
7 hours | Solvent control +S9 | 400 | 10 | 2.50 | 1 | 0.25 | 0.00 | 5.9 | 100.0 |
7 hours | 10 μg/mL test item -S9 | 400 | 14 | 3.50 | 8 | 2.00 | 0.00 | 2.8 | 47.7 |
7 hours | 36 μg/mL test item +S9 | 400 | 28 | 7.00 | 13 | 3.25 | 0.00 | 5.2 | 86.9 |
28 hours | Solvent control -S9 | 400 | 17 | 4.25 | 6 |
1.50 | 0.25 | 4.4 | 100.0 |
28 hours | Solvent control +S9 | 400 | 10 | 2.50 | 2 | 0.50 | 0.00 | 1.9 | 43.1 |
28 hours | 11 μg/mL test item -S9 | 400 | 11 | 2.75 | 6 | 1.50 | 0.5 | 5.7 | 100.0 |
28 hours | 36 μg/mL test item +S9 | 400 | 25 | 6.25 | 10 | 2.50 | 0.00 | 5.7 | 99.1 |
Table 2. Preliminary study results
Treatment group | Number of seeded cells per flask | Mean number of found cells per flask | % PE (absolute) | % PE (relative) |
Untreated control -S9 | 496 | 300.0 | 60.5 | 100.0 |
Untreated control +S9 | 498 | 435.0 | 87.3 | 100.0 |
Solvent control -S9 | 496 | 311.5 | 62.8 | 100.0 |
Solvent control +S9 | 498 | 387.0 | 77.7 | 100.0 |
10.0 μg/mL test item -S9 | 496 | 224.0 | 45.2 | 71.9 |
11.0 μg/mL test item -S9 | 496 | 155.5 | 31.4 | 49.9 |
12.0 μg/mL test item -S9 | 496 | 20.0 | 4.0 | 6.4 |
13.0 μg/mL test item -S9 | 496 | 17.0 | 3.4 | 5.5 |
14.0 μg/mL test item -S9 | 496 | 0.0 | 0.0 | 0.0 |
15.0 μg/mL test item -S9 | 496 | 0.0 | 0.0 | 0.0 |
15.0 μg/mL test item +S9 | 498 | 356.5 | 71.6 | 92.1 |
20.0 μg/mL test item +S9 | 498 | 377.5 | 75.8 | 97.5 |
25.0 μg/mL test item +S9 | 498 | 350.5 | 70.4 | 90.6 |
30.0 μg/mL test item +S9 | 498 | 342.0 | 68.7 | 88.4 |
35.0 μg/mL test item +S9 | 498 | 233.5 | 46.9 | 60.3 |
40.0 μg/mL test item +S9 | 498 | 2.0 | 0.4 | 0.5 |
Table 1. First trial for mutagenic effects without metabolic activation
Test item concentration (μg/plate) | Revertant colonies per plate (± standard deviation) | ||||
Base-pair substitution | Frame-shift | ||||
TA 100 | TA 1535 | TA 98 | TA 1537 | TA 1538 | |
Solvent control (ethanol) | 62 ± 8 | 10 ± 3 | 31 ± 7 | 5 ± 1 | 8 ± 3 |
100 | 57 ± 6 | 10 ± 3 | 28 ± 8 | 5 ± 1 | 7 ± 4 |
500 | 65 ± 10 | 7 ± 3 | 30 ± 6 | 6 ± 1 | 9 ± 5 |
1000 | 44 ± 9 | 8 ± 2 | 27 ± 7 | 5 ± 1 | 7 ± 2 |
5000 | 50 ± 8 | 5 ± 1 | 30 ± 9 | 3 ± 1 | 8 ± 3 |
10000 | 73 ± 13 | 6 ± 0 | 34 ± 6 | 4 ± 1 | 6 ±1 |
15000 | 75 ± 10 | 5 ± 4 | 36 ± 2 | 5 ± 0 | 7 ± 2 |
Table 2. First trial for mutagenic effects with metabolic activation
Test item concentration (μg/plate) | Revertant colonies per plate (± standard deviation) | ||||
Base-pair substitution | Frame-shift | ||||
TA 100 | TA 1535 | TA 98 | TA 1537 | TA 1538 | |
Solvent control | 74± 10 | 13± 6 | 52± 9 | 9± 3 | 20± 4 |
100 | 55± 15 | 11±3 | 39± 5 | 7± 4 | 17± 3 |
500 | 70± 15 | 9± 2 | 41± 8 | 7± 3 | 14± 4 |
1000 | 71± 9 | 10± 3 | 50± 13 | 7± 2 | 14± 6 |
5000 | 61± 5 | 11± 0 | 48± 11 | 8± 3 | 12± 2 |
10000 | 68± 3 | 12± 3 | 50± 2 | 7± 2 | 18± 6 |
15000 | 76± 6 | 14± 5 | 42± 8 | 6± 1 | 18± 5 |
Table 3. Second (repeat) trial for mutagenic effects without metabolic activation
Test item concentration (μg/plate) | Revertant colonies per plate (± standard deviation) | ||||
Base-pair substitution | Frame-shift | ||||
TA 100 | TA 1535 | TA 98 | TA 1537 | TA 1538 | |
Solvent control | 96±10 | 11± 2 | 22± 7 | 7± 2 | 6± 1 |
100 | 87± 13 | 6±2 | 25± 3 | 6± 3 | 5± 2 |
500 | 106± 26 | 9± 4 | 20± 3 | 5 ± 2 | 5± 1 |
1000 | 106± 17 | 12± 5 | 21± 3 | 4± 3 | 3± 2 |
5000 | 97± 5 | 4± 2 | 31± 4 | 5± 1 | 4 ± 2 |
10000 | 107± 8 | 5± 4 | 9± 1 | 2± 2 | 2± 1 |
15000 |
106± 12 |
9± 1 |
18± 5 |
3± 2 |
5± 1 |
Table 4. Second (repeat) trial for mutagenic effects with metabolic activation
Test item concentration (μg/plate) | Revertant colonies per plate (± standard deviation) | ||||
Base-pair substitution | Frame-shift | ||||
TA 100 | TA 1535 | TA 98 | TA 1537 | TA 1538 | |
Solvent control | 97±17 | 16± 5 | 30± 8 | 5± 2 | 17± 2 |
100 | 119± 17 | 15±3 | 24± 3 | 4± 2 | 13± 2 |
500 | 112± 15 | 11± 1 | 40± 17 | 7± 3 | 10± 1 |
1000 | 128± 12 | 12± 2 | 24± 10 | 3 ± 1 | 15± 5 |
5000 | 125± 5 | 17± 5 | 25± 7 | 3± 2 | 11± 5 |
10000 | 124± 15 | 8± 3 | 41± 1 | 6± 4 | 11± 4 |
15000 |
122± 11 |
10± 3 |
28± 4 |
3± 1 |
5± 2 |
Table 1. Summary of results for culture 1
Treatment |
S9 mix |
Relative cloning efficiency (%) |
Relative cell density (%) |
Relative adjusted cloning efficiency (%) | Number of mutant colonies / 10^6 cells | 95% confidence interval |
Solvent control | - | 100.0 | 100.0 | 100.0 | 21.8 | 1.7 - 30.2 |
Positive control (300.00 μg/mL EMS) | - | 103.5 | 85.1 | 88.1 | 253.0 | 1.7 - 30.2 |
Test item (0.75 μg/mL) | - | 101.7 | 108.3 | 110.1 | 14.8 | 1.7 - 30.2 |
Test item (1.50 μg/mL) | - | 102.1 | 91.0 | 92.9 | 10.5 | 1.7 - 30.2 |
Test item (3.00 μg/mL) | - | 102.4 | 106.4 | 109.0 | 21.4 | 1.7 - 30.2 |
Test item (6.00 μg/mL) | - | 102.7 | 89.5 | 91.9 | 30.3 | 1.7 - 30.2 |
Test item (8.00 μg/mL) (X) | - | 10.4 | 53.6 | 5.6 | 43.9 | 1.7 - 30.2 |
Test item (10.00 μg/mL) | - | 7.0 | 28.0 | 2.0 | - | 1.7 - 30.2 |
Test item (12.00 μg/mL) (P) | - | - | 2.9 | ## | ## | 1.7 - 30.2 |
Test item (16.00 μg/mL) (P) | - | ## | ## | ## | ## | 1.7 - 30.2 |
Test item (20.00 μg/mL) (P) | - | ## | ## | ## | ## | 1.7 - 30.2 |
Solvent control | + | 100.0 | 100.0 | 100.0 | 7.2 | 2.0 - 29.4 |
Positive control (2.30 μg/mL DMBA) | + | 81.0 | 98.0 | 79.4 | 124.3 | 2.0 - 29.4 |
Test item (0.78 μg/mL) | + | - | 109.6 | # | - | 2.0 - 29.4 |
Test item (1.60 μg/mL) | + | 94.1 | 124.2 | 116.9 | - | 2.0 - 29.4 |
Test item (3.10 μg/mL) | + | 84.4 | 121.0 | 102.1 | 5.9 | 2.0 - 29.4 |
Test item (6.25 μg/mL) | + | 93.1 | 119.8 | 111.5 | 14.6 | 2.0 - 29.4 |
Test item (12.50 μg/mL) | + | 90.9 | 114.9 | 104.4 | 15.3 | 2.0 - 29.4 |
Test item (25.00 μg/mL) | + | 88.0 | 114.7 | 100.9 | 28.6 | 2.0 - 29.4 |
Test item (50.00 μg/mL) (P) | + | 75.0 | 98.4 | 73.8 | 15.8 | 2.0 - 29.4 |
Test item (100.00 μg/mL) (P) | + | - | 8.1 | ## | ## | 2.0 - 29.4 |
EMS: Ethylmethane sulfonate
DMBA: 7,12 -dimethylbenz(a)anthracene
(P): Precipitation visible at the end of treatment
(X): Data not considered in evaluation due to severe cytotoxicity
#: Culture was not continued as a minimum of only four analysable concentrations are required
##: Culture was not continued due to severe cytotoxic effects
-: Not reported
Table 2. Summary of results for culture 2
Treatment |
S9 mix |
Relative cloning efficiency (%) |
Relative cell density (%) |
Relative adjusted cloning efficiency (%) | Number of mutant colonies / 10^6 cells | 95% confidence interval |
Solvent control | - | 100.0 | 100.0 | 100.0 | 10.0 | 1.7 - 30.2 |
Positive control (300.00 μg/mL EMS) | - | 98.3 | 71.1 | 69.8 | 234.3 | 1.7 - 30.2 |
Test item (0.75 μg/mL) | - | 98.3 | 88.1 | 86.6 | 23.3 | 1.7 - 30.2 |
Test item (1.50 μg/mL) | - | 104.0 | 62.4 | 64.8 | 15.6 | 1.7 - 30.2 |
Test item (3.00 μg/mL) | - | 101.4 | 77.2 | 78.3 | 12.8 | 1.7 - 30.2 |
Test item (6.00 μg/mL) | - | 100.7 | 82.2 | 83.4 | 11.0 | 1.7 - 30.2 |
Test item (8.00 μg/mL) (X) | - | 11.4 | 42.4 | 4.8 | 41.3 | 1.7 - 30.2 |
Test item (10.00 μg/mL) | - | 2.7 | 28.6 | 0.8 | - | 1.7 - 30.2 |
Test item (12.00 μg/mL) (P) | - | - | 1.1 | ## | ## | 1.7 - 30.2 |
Test item (16.00 μg/mL) (P) | - | ## | ## | ## | ## | 1.7 - 30.2 |
Test item (20.00 μg/mL) (P) | - | ## | ## | ## | ## | 1.7 - 30.2 |
Solvent control | + | 100.0 | 100.0 | 100.0 | 7.4 | 2.0 - 29.4 |
Positive control (2.30 μg/mL DMBA) | + | 81.0 | 71.6 | 58.0 | 149.5 | 2.0 - 29.4 |
Test item (0.78 μg/mL) | + | # | # | # | # | 2.0 - 29.4 |
Test item (1.60 μg/mL) | + | 94.8 | 58.1 | 55.1 | - | 2.0 - 29.4 |
Test item (3.10 μg/mL) | + | 99.3 | 69.2 | 68.7 | 16.0 | 2.0 - 29.4 |
Test item (6.25 μg/mL) | + | 94.4 | 66.1 | 62.5 | 21.7 | 2.0 - 29.4 |
Test item (12.50 μg/mL) | + | 49.5 | 70.0 | 34.6 | 24.4 | 2.0 - 29.4 |
Test item (25.00 μg/mL) | + | 55.4 | 84.5 | 46.9 | 14.6 | 2.0 - 29.4 |
Test item (50.00 μg/mL) (P) | + | 39.7 | 45.9 | 18.3 | 20.9 | 2.0 - 29.4 |
Test item (100.00 μg/mL) (P) | + | - | 8.1 | ## | ## | 2.0 - 29.4 |
EMS: Ethylmethane sulfonate
DMBA: 7,12 -dimethylbenz(a)anthracene
(P): Precipitation visible at the end of treatment
(X): Data not considered in evaluation due to severe cytotoxicity
#: Culture was not continued as a minimum of only four analysable concentrations are required
##: Culture was not continued due to severe cytotoxic effects
-: Not reported
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (negative)
Genetic toxicity in vivo
Endpoint conclusion
- Endpoint conclusion:
- no study available
Additional information
Three in vitro studies are available to determine the genetic toxicity of the test item.
The mutagenic potential of the test item to bacteria was determined in Salmonella typhimurium strains TA 98, TA 100, TA 1535, TA 1537 and TA 1538 using a plate incorporation method similar to OECD Guideline 471 (1980). The test substance was incubated with and without metabolic activation (rat liver S-9 mix) at nominal concentrations of 100, 500, 1000, 5000, 10000 and 15000 μg/plate. Two experiments were performed, each consisting of 4 test item replicates and 8 solvent control (ethanol) replicates. 2 -aminoanthracene, 9 -aminoacridine, daunomycin, 1 -ethyl-2 -nitro-3 -nitrosoguanidine, methyl methanesulfonate, N-methyl-N-nitro-N-nitrosoguanidine, 2 -nitrofluorene and 4 -nitro-1,2 -phenylenediamine were tested as the positive controls. The test substance did not show mutagenic activity in any S. typhimurium strain up to 15000 μg/plate, with and without metabolic activation. This study is reliable without restrictions (Klimisch 1).
The potential of the test item to induce chromosomal aberrations was determined in vitro with cells of the V79 Chinese hamster cell line according to OECD Guideline 473 (1986). Chinese hamster lung fibroblasts V79 were treated with the test item at concentrations of 1, 5, 10 and 11 µg/mL without S9-activation and 3, 15 and 36 µg/mL with S9-activation. Cells were incubated with the test item for 4 hours, followed by a 5, 15.5 or 25.5 -hour incubation period in growth medium. Colcemid was added as a fixing agent and the cells were incubated for a further 2.0 or 2.5 hours. The study included negative, solvent and positive (ethyl methanosulfonate and cyclophosphamide) controls. Mutagenicity was evaluated by determining the number of gaps, breaks, fragments, deletions, exchanges and chromosomal disintegrations in 400 metaphases per test concentration. Cytotoxicity was evaluated by determination of mitotic index in 1000 cells in each replicate. The test item was not mutagenic to V79 Chinese hamster cell line in the presence and absence of metabolic activation. This study is considered reliable without restrictions (Klimisch 1).
The potential of the test item to induce gene mutations at the HPRT locus in V79 cells of the Chinese hamster was determined according to OECD Guideline 476, EU Method B.17, EPA OPPTS 870.5300 and Japanese guidelines (2017). The study was conducted in medium at test item concentrations of 0.75, 1.5, 3, 6, 8, 10, 12, 16 and 20 μg/mL in the absence metabolic activation and 0.78, 1.6, 3.1, 6.25, 12.5, 25, 50 and 100 μg/mL in the presence of metabolic activation. A solvent control and positive controls were tested concurrently. Five replicates were assessed per test item treatment and control, and two parallel cultures were used throughout the assay. The treatment period was 4 hours with and without metabolic activation, with a 24 hour pre-exposure period and 7 day expression (post-exposure) period in medium. Cells were fixed and stained with 10% methylene blue in 0.01% KOH solution 8 days after treatment. Precipitation and / or severe cytotoxicity were observed in the four highest test concentation without metabolic activation (10, 12, 16 and 20 μg/mL) and at the highest test concentration with metabolic activation (100 μg/mL), therefore mutation frequency was not assessed for these concentrations. Severe cytotoxicity also occurred in the 8 μg/mL treatment level without metabolic activation, and this data was not taken into the consideration of the evaluation of this assay. No relevant and reproducible increase in mutant colony numbers per 10^6 cells was observed with and without metabolic activation. Therefore, the test item is considered to be non-mutagenic in the HPRT assay. This study is considered to be reliable without restrictions (Klimisch 1).
Justification for classification or non-classification
Three in vitro studies are available to evaluate the genotoxicity of the test item. All studies were considered reliable without restriction (Klimisch 1) and sufficient for classification. None of studies indicated any potential for mutagenicity, clastogenicity or cytogenicity. Consequently, in accordance with the CLP Regulation (EC) No. 1272/2008, the test item is not classified as a genetic toxicant.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.

EU Privacy Disclaimer
This website uses cookies to ensure you get the best experience on our websites.